Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
Go back to Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026| (NASDAQ: XERS) | Delayed: 7.20 +0.30 (4.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.90 | 52 Week High | $ | |||
| Open | $6.90 | 52 Week Low | $ | |||
| Day High | $7.30 | P/E | N/A | |||
| Day Low | $6.86 | EPS | $ | |||
| Volume | 1,978,616 | |||||

